Clinical Trial Update: The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating 0.05% cyclosporine A eye drops for post-refractive surgery dry eye.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• 0.05% CsA eye drops (cyclosporine)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Dry Eye | Phase 4 | Status: UNKNOWN